Do we really need five TNF antagonists?
作者信息
Ruderman Eric M
出版信息
Rheumatology (Oxford). 2010 Jun;49(6):1028-9. doi: 10.1093/rheumatology/keq016. Epub 2010 Feb 19.
PMID:20172993
Abstract
摘要
相似文献
1
Do we really need five TNF antagonists?
Rheumatology (Oxford). 2010 Jun;49(6):1028-9. doi: 10.1093/rheumatology/keq016. Epub 2010 Feb 19.
2
[TNF-alpha antagonists in therapy of rheumatoid arthritis].[肿瘤坏死因子-α拮抗剂在类风湿关节炎治疗中的应用]
Z Rheumatol. 2003 Jun;62(3):217.
3
[TNF antagonists in therapy of rheumatoid arthritis].[肿瘤坏死因子拮抗剂在类风湿关节炎治疗中的应用]
Med Monatsschr Pharm. 1999 Nov;22(11):334-9.
4
[Cost effectiveness of pharmaceutical innovations. Health economic aspects of rheumatoid arthritis treatment with TNF-alpha antagonists].[药物创新的成本效益。肿瘤坏死因子-α拮抗剂治疗类风湿关节炎的卫生经济学方面]
Pharm Unserer Zeit. 2003;32(5):420-5. doi: 10.1002/pauz.200300042.
5
[TNF-inhibitors slow down joint destruction in rheumatoid arthritis. No cure, but dramatic relief of symptoms].[肿瘤坏死因子抑制剂可减缓类风湿性关节炎的关节破坏。虽无法治愈，但能显著缓解症状]
Lakartidningen. 2001 May 23;98(21):2560-2.
6
[TNF-alpha blocker in rheumatoid arthritis. Who should be treated with the new substances?].[类风湿关节炎中的肿瘤坏死因子-α阻滞剂。哪些患者应接受这些新药物治疗？]
MMW Fortschr Med. 2000 Nov 2;142(44):6.
7
[TNF-alpha antibody in rheumatoid arthritis. Efficacy-risk relationship is positively evaluated].[类风湿关节炎中的肿瘤坏死因子-α抗体。疗效-风险关系得到积极评估]
MMW Fortschr Med. 2002 May 16;144(20):65.
8
Rheumatoid arthritis: choice of antirheumatic treatment. Methotrexate first.类风湿关节炎：抗风湿治疗的选择。首选甲氨蝶呤。
Prescrire Int. 2010 Feb;19(105):30-4.
9
Nonresponse to tumor necrosis factor antagonists--is there any point in re-treatment?对肿瘤坏死因子拮抗剂无反应——再次治疗有意义吗？
Nat Clin Pract Rheumatol. 2006 Jun;2(6):288-9. doi: 10.1038/ncprheum0210.
10
The evolving use of tumor necrosis factor inhibitors in rheumatoid arthritis.肿瘤坏死因子抑制剂在类风湿关节炎中的应用进展
J Rheumatol. 2004 Oct;31(10):1881-4.
引用本文的文献
1
Rheumatoid arthritis: IL-6 inhibition in RA--déjà vu all over again?类风湿关节炎：类风湿关节炎中白细胞介素-6的抑制——似曾相识？
Nat Rev Rheumatol. 2015 Jun;11(6):321-2. doi: 10.1038/nrrheum.2015.58. Epub 2015 Apr 28.
Zotero 插件